NEULEPTIL CAPSULE

国: カナダ

言語: 英語

ソース: Health Canada

有効成分:

PERICIAZINE

から入手可能:

SEARCHLIGHT PHARMA INC

ATCコード:

N05AC01

INN（国際名）:

PERICIAZINE

投薬量:

10MG

医薬品形態:

CAPSULE

構図:

PERICIAZINE 10MG

投与経路:

ORAL

パッケージ内のユニット:

15G/50G

処方タイプ:

Prescription

治療領域:

PHENOTHIAZINES

製品概要:

Active ingredient group (AIG) number: 0106194001; AHFS:

認証ステータス:

APPROVED

承認日:

2000-10-17

製品の特徴

PRODUCT MONOGRAPH
PR
NEULEPTIL
_PERICIAZINE CAPSULES _
_ _
_PERICIAZINE ORAL DROPS _
_ _
_ _
_ _
_ _
PSYCHOTROPIC AGENT
Searchlight Pharma Inc.
1600 Notre-Dame West, suite 312
Montreal, Quebec
H3J 1M1
Date of Preparation:
JAN 26, 2023
Submission Control No.: 271076
1
PR
NEULEPTIL®
_PERICIAZINE CAPSULES _
_PERICIAZINE ORAL DROPS _
PSYCHOTROPIC AGENT
ACTION
Periciazine is a phenothiazine of the piperidine group. It has been
shown to reduce pathologic
arousal and affective tension in some psychotic patients, while the
symptoms of abnormal mental
integration are relatively unaffected.
It is a sedative phenothiazine with weak antipsychotic properties. It
also has adrenolytic,
anticholinergic metabolic and endocrine effects, and an action on the
extrapyramidal system.
Like other phenothiazines, it is presumed to act principally in the
subcortical areas, by producing
what has been described as a central adrenergic blockade.
INDICATIONS
As adjunctive medication in some psychotic patients, for the control
of residual prevailing
hostility, impulsiveness and aggressiveness.
CONTRAINDICATIONS
Circulatory collapse, altered states of consciousness or comatose
states, particularly when they
are due to intoxication with central depressant drugs such as alcohol,
hypnotics, analgesics,
narcotics, etc. It should also not be administered in association with
spinal or regional anesthesia.
Periciazine is contraindicated in patients with a history of blood
dyscrasias, liver disease or
hypersensitivity related to other phenothiazines.
WARNINGS
Geriatrics and Debilitated Patients: Particular care should be
exercised when periciazine is given
to elderly or debilitated patients as some appear to be unduly
sensitive to the effects of the drug.
Elderly Patients with Dementia: Elderly patients with dementia-related
psychosis treated with
antipsychotic drugs are at an increased risk of death. Analyses of
seventeen placebo-controlled
trials (modal duration of 10 weeks), largely in patients taking
atypical antipsychotic drugs,
revealed a risk o